The high-potency active pharmaceutical ingredients market is growing rapidly, driven mainly by the increasing global burden of chronic diseases. Key factors contributing to this expansion include the rising prevalence of cancer and diabetes, greater government […]
The polycythemia vera market over the next few years is expected to substantially change and experience growth, as it will be dominated by two already approved products, Incyte/Novartis’ JAKAFI and PharmaEssentia/AOP Orphan Pharmaceuticals’ BESREMi. In […]
The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along with growing R&D efforts and strategic collaborations […]
The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely […]
The spinal cord injury market is expected to experience steady growth, with a strong CAGR of 15.4% forecast from 2024 to 2034. This growth across the 7MM will be propelled by the introduction of innovative […]
